Fact-checked by Grok 2 weeks ago

Immunoglobulin class switching

Immunoglobulin class switching, also known as class-switch recombination (CSR), is a DNA recombination process in mature B lymphocytes that changes the constant region of the , allowing the production of antibodies with altered effector functions—such as opsonization, neutralization, or mucosal secretion—while preserving the same antigen-binding specificity of the variable region. This switch typically progresses from the initial IgM (and IgD) isotypes to downstream classes like IgG, IgA, or IgE, enabling adaptive immune responses to diversify beyond the broad, pentameric structure of IgM. The molecular mechanism of CSR begins with the enzyme activation-induced cytidine deaminase (AID), which deaminates cytosines to uracils within repetitive G-rich switch (S) regions located upstream of each constant region gene (C_H) in the immunoglobulin heavy chain locus on chromosome 14 in humans. These deamination events trigger the formation of staggered DNA double-strand breaks (DSBs) through base excision repair and mismatch repair pathways, creating free ends in two S regions that are then ligated by the non-homologous end joining (NHEJ) machinery, including proteins like Ku70/80, DNA-PKcs, and ligase IV, resulting in the excision of the intervening DNA loop and permanent isotype commitment. Transcription through the S regions is essential for AID targeting, as it generates R-loops that expose single-stranded DNA substrates. Regulation of CSR occurs at multiple levels to ensure precise isotype selection and prevent aberrant recombination. Extracellular signals from T follicular helper cells, such as CD40 ligand (CD40L) engagement and cytokines (e.g., IL-4 directing IgG1 and IgE switching, IFN-γ promoting IgG3, or TGF-β favoring IgA), activate intracellular signaling cascades involving transcription factors like STAT6, , and Bcl-6. At the level, germline transcription from intronic promoters (I exons) enhances S region accessibility via epigenetic modifications, including acetylation and , while long-range enhancers like the 3' regulatory region (3'RR) and /cohesin-mediated looping facilitate spatial proximity between distant S regions during the of the . Defects in these regulatory elements can lead to inefficient switching or genomic instability. Biologically, immunoglobulin class switching is pivotal for , as it tailors responses to specific pathogens and anatomical sites—for instance, IgA dominates mucosal defenses, while IgG facilitates systemic clearance and long-lived differentiation. Occurring primarily in germinal centers of secondary lymphoid organs post-antigenic , CSR contributes to maturation and the generation of high-affinity, class-switched B cells and cells, thereby underpinning efficacy and protective immunity.

Overview

Definition

Immunoglobulin class switching, also known as class switch recombination (CSR), is a DNA recombination process that occurs in activated mature B cells, enabling them to change the constant region (C_H) of the from the default IgM (μ) to other isotypes such as IgG (γ), IgA (α), or IgE (ε), while preserving the variable (V_H) region and thus the antigen-binding specificity of the . This alteration diversifies the effector functions of without affecting their ability to recognize specific antigens, allowing the to tailor responses to different pathogens and contexts. The process takes place primarily in the germinal centers of secondary lymphoid organs, such as lymph nodes and , following T cell-dependent activation by antigens. In the locus, the constant region s are arranged sequentially as Cμ (IgM), Cδ (IgD), followed by various Cγ s encoding IgG subclasses, Cα (IgA), and Cε (IgE), with recombination deleting the intervening DNA segments to juxtapose the VDJ segment with a downstream C_H . Class switching is distinct from (SHM), which introduces point mutations in the V region to drive affinity maturation and improve binding strength; in contrast, CSR targets the C_H region to modify isotype-specific functions like complement activation or mucosal secretion. The choice of downstream isotype is briefly influenced by specific cytokines from T helper cells, directing the response toward humoral, cellular, or allergic immunity.

Biological significance

Immunoglobulin class switching plays a pivotal role in adaptive immunity by allowing B cells to produce antibodies with the same specificity but diverse effector functions, thereby optimizing the humoral response to various pathogens without altering the variable region. This process enables the transition from the initial IgM isotype, which is effective for early complement and due to its pentameric and high , to downstream isotypes like IgG, IgA, and IgE that mediate specialized activities. For instance, IgG facilitates opsonization and by binding Fcγ receptors on immune cells, can activate complement via the classical pathway (though less efficiently than IgM), and enables transplacental transfer to provide neonatal immunity via the neonatal (FcRn). Similarly, IgA supports mucosal immunity through neutralization of pathogens and toxins at epithelial surfaces, such as in the gut and , while IgE promotes defense against parasitic helminths by triggering and , though it also underlies allergic responses. By tailoring antibody isotypes to the nature of the invading and the site of infection, class switching enhances the efficiency of across different s and challenges. For bacterial infections, IgG predominates for systemic opsonization and , whereas IgE is preferentially induced against helminths to expel large parasites through immediate reactions. In mucosal environments like the , IgA dimers secreted across epithelia prevent microbial and invasion, forming a first line of defense that is crucial for containing commensal and pathogenic flora. This adaptability ensures that immune responses are not only rapid but also precisely matched to the pathogen's characteristics, such as size, location, and evasion strategies, thereby improving pathogen clearance and reducing damage. The process is evolutionarily conserved across vertebrates, reflecting its fundamental importance in diversifying functions while maintaining specificity, with switch regions showing repetitive motifs that facilitate recombination in diverse . Class switching also underpins the formation of long-lived memory B cells and plasma cells that predominantly produce switched isotypes, such as IgG, ensuring durable protection against reinfection. This contributes significantly to efficacy, as class-switched antibodies, often of higher due to concurrent , provide more effective and long-term neutralization compared to the transient IgM-dominated primary response. Defects in switching, while not detailed here, underscore its necessity for robust immunity.

Molecular Mechanism

Role of activation-induced cytidine deaminase

Activation-induced cytidine deaminase (AID) is a single-stranded DNA-specific cytidine deaminase enzyme that is selectively expressed in activated B cells within of secondary lymphoid organs. Its expression is tightly regulated and induced by T cell-dependent signals, including engagement of CD40 on B cells by CD40 ligand (CD40L) expressed on activated T helper cells, in combination with cytokines such as interleukin-4 (IL-4). This induction occurs during the germinal center reaction, where B cells undergo and in response to antigenic . The core enzymatic activity of in immunoglobulin class switch recombination (CSR) involves the of (C) to (U) within the DNA of switch (S) regions, generating mismatched U:G base pairs. This reaction can be represented as: \ce{C -> U} in single-stranded DNA substrates, which are preferentially accessed during transcription when the non-template strand is exposed. The resulting U:G mismatches are recognized by uracil-DNA glycosylase (UNG) and mismatch repair proteins, initiating or mismatch repair pathways that culminate in the formation of double-strand breaks (DSBs) essential for CSR. These DSBs are subsequently processed by mechanisms to join donor and acceptor S regions. AID specifically targets the repetitive S regions located upstream of the constant region genes (C_H) in the immunoglobulin heavy chain locus, acting only on regions that are actively transcribed into non-coding germline transcripts. These S regions consist of G-rich, repetitive sequences that promote the formation of R-loop structures—RNA-DNA hybrids that expose the non-template DNA strand as single-stranded DNA, the preferred substrate for AID.30492-6) AID exhibits enhanced deamination efficiency in these G-rich sequences due to their ability to stabilize secondary structures like R-loops, which facilitate AID recruitment and activity during transcription. This targeted action ensures that mutations are confined to the S regions, sparing the variable region and preserving antigen specificity. Regulation of AID expression occurs primarily at the transcriptional level through activation of by CD40L signaling and factors, such as STAT6, by cytokines like IL-4. These transcription factors bind to promoter and enhancer elements in the Aicda gene, synergistically driving AID mRNA production in response to combined stimuli. Post-translational modifications further modulate AID function; for instance, at serine 38 enhances AID's interaction with cofactors and its nuclear localization, thereby increasing efficiency. Although AID initiates both CSR and somatic hypermutation (SHM), its role in CSR is distinguished by precise targeting to S regions via transcription-dependent access and sequence-specific preferences. In SHM, AID similarly deaminates cytosines but acts on variable region exons to introduce point mutations that refine antibody affinity, whereas in CSR, the clustered lesions in S regions drive large-scale recombination events. This dual functionality underscores AID's central position in B cell diversification, with CSR-specific outcomes arising from the unique architecture and repair processing of S region substrates.

DNA recombination and repair

Following the deamination of cytosines to uracils by activation-induced cytidine deaminase (AID) in switch (S) regions, which are repetitive DNA sequences (1-10 kb in length) located 1-10 kb upstream of constant region (C) genes in the immunoglobulin heavy chain locus, these mismatches are processed into double-strand breaks (DSBs). Uracil-DNA glycosylase (UNG) initiates base excision repair (BER) by excising uracils, creating abasic sites that lead to single-strand breaks, while mismatch repair (MMR) proteins such as MSH2, MSH6, MLH1, and PMS2 recognize U:G mismatches and generate additional nicks, ultimately resulting in staggered DSBs across the S regions. In the loop-out deletion model of class switch recombination (CSR), DSBs form independently in upstream donor S regions (e.g., Sμ for IgM) and downstream acceptor S regions (e.g., Sγ1 for IgG1), allowing the intervening DNA segment to be excised as an extrachromosomal circular fragment containing the unused constant genes. This deletion joins (VDJ) region directly to the selected downstream constant region, replacing the original isotype while preserving specificity.00706-7) The primary repair pathway for these DSBs is classical non-homologous end joining (c-NHEJ), which ligates the broken ends with minimal processing; key components include the Ku70/Ku80 heterodimer that binds DSB ends and recruits DNA-dependent protein kinase catalytic subunit (DNA-PKcs), followed by Artemis for end processing and the ligase IV/XRCC4/XLF complex for final sealing. In the absence of efficient c-NHEJ, alternative end-joining (Alt-EJ) serves as a backup, utilizing microhomology (typically 2-20 bp) at the break ends and involving proteins such as PARP1, CtIP, and DNA polymerase theta (POLQ) to promote resection and annealing. CSR is largely irreversible because the loop-out deletion permanently removes upstream S regions and intervening constant genes, preventing reversion to the germline configuration without rare events. Efficiency of joining is influenced by S region length, with longer regions (up to ~4-12 kb) supporting higher CSR rates by providing more opportunities for DSB formation and , and by sequence between donor and acceptor S regions, which facilitates precise alignment and microhomology-mediated repair. However, imperfect or excessive resection can lead to off-target DSB joining, increasing risks of genomic instability such as interchromosomal translocations.00706-7)

Regulation

Cytokine-mediated signals

Cytokines produced by T helper cells play a pivotal role in directing immunoglobulin class switch recombination (CSR) by selectively activating germline promoters upstream of switch (S) regions, thereby determining the antibody isotype expressed by B cells. These soluble factors, including interleukin-4 (IL-4) from Th2 cells, interferon-gamma (IFN-γ) from Th1 cells, transforming growth factor-beta (TGF-β) from regulatory T cells, and IL-21 from T follicular helper (Tfh) cells, bind to specific receptors on B cells, triggering intracellular signaling cascades that enhance accessibility of target S regions to activation-induced cytidine deaminase (AID). This process is essential for tailoring the humoral immune response to diverse pathogens, such as promoting IgE for parasitic infections or IgA for mucosal immunity. In humans, cytokine signals exhibit distinct preferences for isotype switching, influenced by the Th subset and environmental context. For instance, IL-4, primarily secreted by Th2 cells during allergic or helminth responses, drives switching to IgG1 and IgE by inducing germline transcription of the Iγ1 and Iε exons through STAT6 activation. Conversely, IFN-γ from Th1 cells favors IgG3 production and suppresses IgE switching, supporting antiviral and intracellular pathogen defense via STAT1-mediated pathways. TGF-β promotes IgA class switching, crucial for mucosal barriers, by engaging SMAD2/3/4 transcription factors, while IL-21 from Tfh cells enhances switching to IgG subclasses and IgA, with additional promotion of IgE in certain contexts via STAT3. These effects are summarized in the following table for key human cytokines and their primary isotypes:
CytokinePrimary SourcePromoted IsotypesKey Signaling Factor
IL-4Th2 cellsIgG1, IgESTAT6
IFN-γTh1 cellsIgG3 (suppresses IgE)
TGF-βRegulatory T cellsIgASMAD2/3/4
IL-21Tfh cellsIgG, IgA (enhances IgE)
In mice, cytokine-directed switching shows similarities but notable species-specific differences, reflecting variations in immunoglobulin gene organization and immune priorities. IL-4 from Th2 cells induces IgG1 and IgE, mirroring IgE promotion but targeting a distinct IgG subclass. IFN-γ drives IgG2a (and to a lesser extent IgG2b/IgG3) switching in mice, equivalent to IgG3 in function but absent in human equivalents, as mice lack an IgG3 homolog and rely on IgG2a for Th1-associated responses. TGF-β similarly induces IgA, often in combination with IL-5 or IL-10 for enhanced efficiency, while IL-21 supports IgG1, IgG2b, and IgA production. These divergences arise from differences in S region promoters and binding sites, underscoring the need for species-specific models in research. The signaling mechanisms underlying cytokine directionality involve the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, where ligand binding to cytokine receptors recruits JAK kinases to phosphorylate and activate specific STAT proteins. For example, IL-4 receptor engagement leads to STAT6 dimerization and nuclear translocation, where it binds to consensus sequences in Iε and Iγ1 promoters, facilitating RNA polymerase II recruitment and AID targeting to Sε and Sγ1 regions. Similarly, IFN-γ activates STAT1, which upregulates Iγ3 transcription while repressing STAT6 to inhibit IgE switching, and TGF-β signals through receptor-associated SMADs to activate Iα promoters via cooperation with RUNX3. IL-21 utilizes STAT3 to broadly enhance CSR efficiency across multiple isotypes by amplifying germline transcripts. These pathways ensure precise isotype selection by integrating cytokine cues with B cell activation status. Cytokine-mediated CSR requires synergy with T cell costimulatory signals, particularly CD40 ligand (CD40L) expressed on activated CD4+ T cells, which engages CD40 on B cells to induce global expression and activation. This interaction amplifies cytokine effects; for instance, CD40L crosslinking with or TGF-β markedly increases switching frequencies to IgE or IgA, respectively, by promoting formation and B-T cell cognate interactions. Without CD40L, cytokine signals alone yield minimal CSR, highlighting the dual-signal requirement for efficient humoral adaptation.

Gene regulatory sequences and transcription

Switch (S) regions are repetitive, G-rich DNA sequences located upstream of the constant region genes (C_H) in the immunoglobulin heavy chain (IgH) locus, with lengths varying by isotype; for example, the Sμ region is approximately 4 kb long and consists of tandem repeats rich in guanine bases on the non-template strand. These sequences are essential for class switch recombination (CSR), as germline transcription through them is required to generate R-loops—structures in which the nascent RNA hybridizes with the template DNA strand, exposing single-stranded DNA that serves as a substrate for targeting by activation-induced cytidine deaminase (AID). Germline transcription initiates from I exon promoters (I promoters) upstream of each S region, such as Iε for the IgE isotype, producing non-coding sterile transcripts that traverse the associated S region. These promoters contain binding sites for transcription factors that are activated in response to cytokines, enabling isotype-specific expression. The 3' regulatory region (3'RR), a super-enhancer spanning about 25-30 kb downstream of the Cα gene, plays a central role in coordinating long-range transcriptional activation across the locus; it includes multiple DNase I-hypersensitive sites (hs1-4) that function as enhancers and CTCF-bound insulators, facilitating chromatin looping to bring distant S regions into proximity for transcription. Epigenetic modifications further regulate accessibility of S regions for transcription and recombination. Active S regions exhibit increased histone acetylation (e.g., H3K9ac) and trimethylation of at 4 (), marks that correlate with open and facilitate AID recruitment; these modifications are enriched upon B cell stimulation and are dependent on complexes like MLL for H3K4 . Locus contraction, mediated by 3D folding involving the 3'RR and other elements, brings upstream VDJ and downstream S regions together, enhancing transcriptional contacts and CSR efficiency. The linear arrangement of C_H genes in the IgH locus favors sequential switching, where recombination to a downstream isotype deletes intervening sequences, preventing reversion to upstream classes. In rare cases, "locus suicide" recombination can occur, involving AID-mediated breaks that delete all downstream C_H genes, resulting in loss of IgH expression and B cell death as a regulatory .

Clinical and Pathological Aspects

Disorders linked to defective switching

Defective immunoglobulin class switching is implicated in several primary immunodeficiencies and pathological conditions, where impaired recombination leads to imbalances in antibody isotypes and compromised immune responses. Hyper-IgM (HIGM) syndromes represent a primary group of disorders characterized by normal or elevated serum IgM levels alongside markedly reduced IgG, IgA, and IgE, resulting from blocked class-switch recombination (CSR) and increased susceptibility to recurrent bacterial, viral, and opportunistic infections. These syndromes are genetically heterogeneous, with the X-linked form (HIGM1) caused by mutations in the CD40LG gene encoding CD40 ligand (CD40L), which disrupts T cell-dependent activation essential for CSR initiation. Autosomal recessive forms include HIGM2 due to mutations in AICDA (encoding activation-induced cytidine deaminase, ), which directly impairs the DNA deamination step of CSR, and HIGM5 from UNG mutations affecting uracil removal during recombination, both leading to similar isotype profiles and . In (CVID), a more heterogeneous disorder, partial defects in CSR contribute to in a subset of patients, often linked to dysregulation of expression or impairments in the (NHEJ) pathway required for repairing CSR-induced DNA breaks. These defects result in variably reduced switched isotypes (IgG, IgA, IgE) with normal or low IgM, manifesting as recurrent sinopulmonary infections, , and gastrointestinal complications due to inadequate . Dysregulated CSR also underlies certain autoimmune and atopic conditions. Excessive switching to IgE, driven by aberrant cytokine signaling (e.g., IL-4/IL-13), is central to atopic diseases such as allergic asthma, , and food allergies, where elevated IgE promotes and . Conversely, selective IgA deficiency, the most common , arises from failed CSR to IgA, compromising mucosal barriers and increasing risks of gastrointestinal infections, , and allergic disorders due to impaired secretory immunity at respiratory and intestinal surfaces. Aberrant CSR poses oncogenic risks by generating erroneous DNA breaks that lead to chromosomal translocations in . In , the t(8;14) translocation juxtaposes the proto-oncogene with the IGH locus, often occurring at switch regions during misguided CSR, driving uncontrolled proliferation. Similarly, in , the t(14;18) translocation involving and IGH arises from illegitimate CSR, inhibiting and promoting survival. Diagnosis of these disorders typically involves serological profiling revealing elevated IgM with low or absent switched isotypes, alongside functional assays showing defective CSR in B cells. confirms mutations in key genes such as CD40LG, AICDA, or UNG, guiding precise classification and management.

Therapeutic implications

Understanding of immunoglobulin class switching has significant therapeutic implications, particularly in engineering antibodies and modulating immune responses for various diseases. In therapies, the isotype of the antibody is deliberately selected or engineered to optimize effector functions such as (ADCC). For instance, rituximab, an anti-CD20 used in cancer and autoimmune treatments, is an IgG1 isotype that promotes strong ADCC by binding to Fcγ receptors on immune effector cells. Similarly, engineering antibodies to IgG1 enhances their efficacy in eliminating target cells in and by leveraging Fc-mediated immune activation. Vaccine design benefits from strategies that promote class switch recombination (CSR) toward IgG subclasses to improve long-term and pathogen neutralization. Adjuvants that mimic T follicular helper (Tfh) cell signals, such as those enhancing formation, have been shown to boost Tfh activation and subsequent CSR to IgG, leading to more durable responses in viral vaccines. For example, combination adjuvants targeting lymph node follicles amplify CSR and humoral responses against antigens like Env and spike proteins. Gene therapy approaches leverage / to correct defects in CSR machinery, restoring switching in primary immunodeficiencies. In X-linked hyper-IgM syndrome caused by CD40L mutations, site-specific of hematopoietic stem cells has demonstrated restoration of regulated CD40L expression and functional CSR, with ongoing preclinical and early clinical efforts, including a single-participant base (NCT06959771) for a specific CD40L as of 2025. Similarly, enhancements in efficiency using DNA-PK inhibitors have improved -based correction of CD40L in hyper-IgM, with ongoing preclinical and early clinical efforts. For AID deficiencies, holds potential to reinstate CSR, though applications remain in early development for these immunodeficiencies. In treatments for allergic conditions like , blocking cytokine signals that drive IgE switching offers targeted . Dupilumab, a inhibiting the IL-4 receptor α subunit, blocks both IL-4 and IL-13 signaling, thereby reducing IgE production and in allergen-induced responses. Clinical studies confirm that this inhibition correlates with decreased IgE class switching and improved outcomes in moderate-to-severe . Emerging research focuses on modulating CSR regulators for precise therapeutic control. Inhibitors targeting activation-induced cytidine deaminase () are being explored to suppress aberrant CSR in B-cell lymphomas, where off-target AID activity contributes to genomic instability, though clinical trials as of 2025 remain preclinical. Additionally, targeting the 3' regulatory region (3'RR) of the locus shows promise for isotype-specific CSR modulation, with recent studies demonstrating its role in optimizing IgH locus positioning and enhancer activity to fine-tune antibody responses.

References

  1. [1]
    Immunoglobulin class‐switch recombination: Mechanism, regulation ...
    This review provides a comprehensive review of the molecular pathogenesis of typical diseases associated with antibody diversification imbalance. It ...
  2. [2]
    Long-Range Control of Class Switch Recombination by ... - Frontiers
    Sep 13, 2021 · Immunoglobulin class switch recombination (CSR) plays a crucial role in adaptive immune responses through a change of the effector functions ...
  3. [3]
    Immunoglobulin class-switch recombination: Mechanism, regulation ...
    Aug 13, 2024 · Here, we review the most recent insights on the diversification of five Ig isotypes and choose several classic diseases, including hyper-IgM ...
  4. [4]
    Current insights into the mechanism of mammalian immunoglobulin ...
    Immunoglobulin (Ig) class switch recombination (CSR) is the gene rearrangement process by which B lymphocytes change the Ig heavy chain constant region.
  5. [5]
    Class-Switch Recombination Occurs Infrequently in Germinal Centers
    Aug 20, 2019 · Class-switch recombination (CSR) is a DNA process that replaces the immunoglobulin constant region. It is triggered before GC differentiation ...
  6. [6]
    Regulation of immunoglobulin class-switch recombination - PubMed
    Upon encountering antigens, mature IgM-positive B lymphocytes undergo class-switch recombination (CSR) wherein exons encoding the default Cμ constant coding ...
  7. [7]
    The distribution and functions of immunoglobulin isotypes - NCBI - NIH
    Each human immuno-globulin isotype has specialized functions and a unique distribution. The major effector functions of each isotype (+ + +) are shaded in ...9-12. Antibodies of different... · 9-13. Transport proteins that...
  8. [8]
    Immunoglobulin class switch DNA recombination - PubMed Central
    Class switch DNA recombination (CSR) of the immunoglobulin heavy chain (IgH) locus is central to the maturation of the antibody response.
  9. [9]
    Induction of activation‐induced cytidine deaminase gene expression ...
    Activation‐induced cytidine deaminase (AID) is an inducible gene that plays an important role in class switch recombination, somatic hypermutation and gene ...Results · Il‐4 Induces Stat6 Binding... · Cd40 Ligation Induces Nfκb...
  10. [10]
    Expression of activation-induced cytidine deaminase is regulated by ...
    For example, IL-4 and CD40 signals synergized to promote AID expression by B cells in a Stat-6- and NF-κB-dependent fashion, whereas either stimuli alone failed ...
  11. [11]
    AID Recognizes Structured DNA for Class Switch Recombination
    Aug 3, 2017 · Activation-induced cytidine deaminase (AID) initiates both class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification.
  12. [12]
    Phosphorylation promotes activation-induced cytidine deaminase ...
    Nov 9, 2017 · Activation-induced cytidine deaminase (AID) initiates antibody diversification by introducing U:G mismatches in the Ig genes of activated B ...Missing: seminal | Show results with:seminal
  13. [13]
    Role for Mismatch Repair Proteins Msh2, Mlh1, and Pms2 in ...
    Class switching occurs by a DNA recombination event that results in exchanging the constant region of the Ig heavy chain, without changing the antibody variable ...
  14. [14]
    Influence of switch region length on immunoglobulin class ... - PNAS
    CSR results from recombination between the most 5′ S region ... We find that, at least up to 4 kb, the length of S region directly influences CSR efficiency in ...
  15. [15]
    Involvement of Artemis in nonhomologous end-joining during ...
    Dec 15, 2008 · The classical NHEJ machinery requires a set of proteins, including Ku70, Ku80, DNA-PKcs, DNA ligase IV, XRCC4, Artemis and the recently ...
  16. [16]
    Alternative end-joining catalyzes class switch recombination in the ...
    Feb 8, 2010 · In the absence of XRCC4 or Lig4, substantial CSR occurs via “alternative” end-joining (A-EJ) that generates largely MH-mediated joins. Because ...
  17. [17]
  18. [18]
    Immunoglobulin class‐switch recombination: Mechanism, regulation ...
    Aug 13, 2024 · AID initiates the deamination of cytosine to uracil in the S and IgV region ... class-switch recombination via germline deletion of the IgH ...
  19. [19]
    Structural variation in immunoglobulin constant regions - NCBI - NIH
    The μ switch region (Sμ) consists of about 150 repeats of the sequence [(GAGCT)n (GGGGGT)], where n is usually 3 but can be as many as 7. The sequences of ...4-15. The immunoglobulin... · 4-18. Antibody C regions...
  20. [20]
    Mechanism of R-Loop Formation at Immunoglobulin Class Switch ...
    R-loops have been described in vivo at the immunoglobulin class switch sequences and at prokaryotic and mitochondrial origins of replication.
  21. [21]
    The role of germline promoters and I exons in cytokine-induced ...
    Germline transcription precedes class switch recombination. The promoter regions and I exons of these germline transcripts include binding site for activation ...
  22. [22]
    The role of germline promoters and I exons in cytokine-induced ...
    Jan 1, 2011 · The promoter regions and I exons of these germline transcripts include binding sites for activation- and cytokine-induced transcription factors ...
  23. [23]
    Functional anatomy of the immunoglobulin heavy chain 3΄ super ...
    Mar 22, 2017 · The mouse IgH 3΄ regulatory region (3'RR), a major B-cell super-enhancer, consists of four of such core enhancers, scattered throughout more ...Missing: CTCF insulators
  24. [24]
    The role of CTCF binding sites in the 3′ immunoglobulin heavy ...
    Nov 15, 2012 · Here we address the 3′ RR CTCF-binding region as a potential insulator of the Igh locus, an independent regulatory element and a predicted modulator of the ...
  25. [25]
    Epigenetic Codes Programing Class Switch Recombination - PMC
    Jul 23, 2015 · Histone modifications like H3K4me3 and H3K9ac are present at Sμ in naïve B cells and increases upon stimulation (16–19). These are marks ...
  26. [26]
    Roles for histone H3K4 methyltransferase activities during ...
    Recent work suggests roles for this histone mark and different MLL-like complexes in mature B cells during immunoglobulin class-switch recombination.Missing: contraction 3D
  27. [27]
    Three dimensional architecture of the Igh locus facilitates class ... - NIH
    Immunoglobulin (Ig) class switch recombination (CSR) is responsible for diversification of antibody effector function during an immune response.Missing: contraction 3D
  28. [28]
    Molecular Mechanism of Class Switch Recombination: Linkage with ...
    Apr 1, 2002 · Transcription of the S and V regions, which contain palindromic sequences, leads to transient denaturation, forming the stem-loop structure that ...
  29. [29]
    Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes ...
    Sep 26, 2018 · The CSR/HIGM syndromes are defined by the presence of normal or elevated plasma IgM levels in the context of low levels of switched IgG, IgA, and IgE isotypes.
  30. [30]
    CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM ...
    Abnormalities in the CD40L gene were associated with an X-linked immunodeficiency in humans [hyper-IgM (immunoglobulin M) syndrome]. This disease is ...
  31. [31]
    Novel antibody switching defects in human patients - JCI
    Mutations in the CD40-ligand or CD40-receptor impair proper B cell activation and are the cause of HIGM1 and HIGM3 respectively. Mutations in activation-induced ...
  32. [32]
    B cells from hyper-IgM patients carrying UNG mutations lack ability ...
    Moreover, the UNG mutations lead to increased accumulation of genomic uracil. One mutation results in an F251S substitution in the UNG catalytic domain.
  33. [33]
    Immunoglobulin class-switch recombination deficiencies - PMC
    Immunoglobulin class-switch recombination deficiencies (Ig-CSR-Ds) are rare primary immunodeficiencies characterized by defective switched isotype (IgG/IgA/IgE) ...
  34. [34]
    Immunoglobulin class switch recombination deficiencies
    Class switch recombination is a process of DNA recombination between two different switch (S) regions located upstream of the constant (C) regions, while the ...Missing: paper | Show results with:paper
  35. [35]
    The regulation of immunoglobulin E class-switch recombination
    Immunoglobulin E (IgE) isotype antibodies are associated with atopic disease, namely allergic rhinitis, asthma and atopic dermatitis, but are also involved ...
  36. [36]
    The clinical implications of selective IgA deficiency - ScienceDirect
    Selective IgA deficiency is the most common primary immunodeficiency. It is associated with an increased risk of infections, allergic and autoimmune diseases, ...
  37. [37]
    Immunodeficiency and Mucosal Immunity - PMC - PubMed Central
    Whatever genetic abnormality may underlie IgA deficiency, it is not always a stable defect, since IgA deficiency can disappear spontaneously, can be induced by ...
  38. [38]
  39. [39]
  40. [40]
    t(14;18) Translocations and Risk of Follicular Lymphoma - PMC - NIH
    Like follicular lymphoma, t(14;18)-positive cells have undergone class-switch recombination of the nonproductive translocated IgH allele, lending further ...
  41. [41]
    Hyper IgM syndromes (HIGM) - Immune Deficiency Foundation
    Hyper IgM syndromes (HIGM) are characterized by decreased levels of immunoglobulin G (IgG) in the blood and normal or elevated levels of immunoglobulin M (IgM).
  42. [42]
    X-Linked Hyper IgM Syndrome - GeneReviews® - NCBI Bookshelf
    May 31, 2007 · X-linked hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG, IgA, and IgE.
  43. [43]
    Autosomal Recessive Hyper IgM Syndrome (AID, UNG, CD40)
    The CD40-CD40L interaction is responsible for inducing antibody class-switching (from IgM to IgG, IgA, and IgE) and generating memory B cells. As a result, ...
  44. [44]
    Influence of immunoglobulin isotype on therapeutic antibody function
    In this review, we describe how mAb isotype, which dictates FcγR binding specificity and other structural characteristics, critically influences mAb activity.Missing: switching | Show results with:switching
  45. [45]
    How to select IgG subclasses in developing anti-tumor therapeutic ...
    May 5, 2020 · It has been well confirmed that antibodies with enhanced ADCC activity against some particular targets showed significantly better therapeutic ...Missing: switching | Show results with:switching
  46. [46]
    Isotype selection for antibody‐based cancer therapy - PMC - NIH
    Here, we discuss the current knowledge of the therapeutic effector functions of different isotypes and Fc‐engineering strategies to improve mAbs application.
  47. [47]
    Role of T Follicular Helper Cells in Viral Infections and Vaccine Design
    Vaccine type significantly affects Tfh cell activation and overall efficacy. Live attenuated vaccines induce the strongest Tfh responses, mimicking ...2. T Follicular Helper Cells · 4. Targeting Tfh Cells... · 4.2. Rna Vaccines: Immunity...
  48. [48]
    Harnessing T Follicular Helper Cell Responses for HIV Vaccine ...
    We report on strategies to optimize Tfh and GC responses for the induction of effective antibody responses, some of which have already shown some success in non ...3. T-Cell Dependent Antibody... · 6. Tfh Cells During Hiv... · 7. Induction Of Tfh...
  49. [49]
    Vaccines combining slow delivery and follicle targeting of antigens ...
    Aug 19, 2024 · We discovered that this combination adjuvant approach showed striking amplification of humoral responses to both HIV Env and SARS-CoV-2 antigens ...Results · Scrna-Seq Profiling Of... · Env Trimer Antigen Delivered...
  50. [50]
    Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X ...
    May 29, 2018 · X-linked hyper-immunoglobulin M (hyper-IgM) syndrome (XHIM) is a primary immunodeficiency due to mutations in CD40 ligand that affect immunoglobulin class- ...Missing: AID | Show results with:AID
  51. [51]
    CRISPR/Cas9 applications in gene therapy for primary ...
    CRISPR/Cas9 applications in gene therapy for primary immunodeficiency ... Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
  52. [52]
    DNA-PK inhibition enhances gene editing efficiency in HSPCs for ...
    Jul 26, 2024 · DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome.
  53. [53]
    Advances in CRISPR/Cas gene therapy for inborn errors of immunity
    Here, we discuss the advances in and issues associated with CRISPR/Cas gene editing tools and their potential as therapeutic alternatives for IEIs.Introduction · Gene editing systems mediate... · CRISPR/Cas based gene...
  54. [54]
    Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα ...
    We demonstrate that blockade of both IL‐4 and IL‐13 is required to broadly block type 2 inflammation, which translates to protection from allergen‐induced lung ...
  55. [55]
    Dupilumab treatment decreases MBC2s, correlating with reduced ...
    Jul 20, 2024 · Dupilumab, an mAb targeting the IL-4 receptor α (IL-4Rα) subunit, inhibits IL-4 and IL-13 signaling. These cytokines contribute ...
  56. [56]
    Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to ...
    Dupilumab blocks the shared receptor component for IL-4 and IL-13, key drivers of type 2 inflammation, including IgE-mediated allergic inflammation in asthma.
  57. [57]
    Targeting type 2 immunity and the future of food allergy treatment
    Mar 3, 2023 · They found that blocking IL-4/IL-13 signaling inhibited the production of allergen-induced specific IgE in a human PBMC model system ex vivo ...<|separator|>
  58. [58]
    Excessive activation‑induced cytidine deaminase accumulated by ...
    Apr 4, 2025 · Activation‑induced cytidine deaminase (AID) is an enzyme that plays a crucial role in mediating somatic hypermutation and class‑switch ...
  59. [59]
    Core enhancers of the 3′RR optimize IgH nuclear position and ...
    Oct 16, 2024 · We conclude that the 3′RR core enhancers are necessary and sufficient to pre-organize the position and conformation of IgH loci in resting B-cell nuclei.
  60. [60]
    The immunoglobulin heavy chain super enhancer controls class ...
    Mar 28, 2024 · Class switch recombination (CSR) plays an important role in adaptive immune response by enabling mature B cells to replace the initial IgM ...Missing: review | Show results with:review